NPI: 1821291147 · JACKSONVILLE, FL 32225 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/06/2007
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 06/06/2007 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,256 | $1.03M |
| 2019 | 10,140 | $2.02M |
| 2020 | 4,157 | $596K |
| 2021 | 397 | $56K |
| 2022 | 178 | $35K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 7,909 | 400 | $1.24M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 7,394 | 602 | $1.23M |
| J1270 | Injection, doxercalciferol, 1 mcg | 4,920 | 399 | $660K |
| A4657 | Syringe, with or without needle, each | 761 | 457 | $202K |
| J1756 | Injection, iron sucrose, 1 mg | 786 | 162 | $163K |
| 85041 | 257 | 214 | $49K | |
| 85048 | 237 | 199 | $46K | |
| 83550 | 200 | 166 | $32K | |
| 83540 | 200 | 166 | $32K | |
| 83970 | 185 | 150 | $32K | |
| 82728 | 121 | 101 | $20K | |
| 82108 | 112 | 95 | $20K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 46 | 39 | $13K |